Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4 | $11 | $7 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $7 | $14 | $10 | $9 |
| Revenue | $5 | $5 | $4 | $5 |
| % Growth | 3.5% | 18.1% | -5.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 23.3% | 23.4% | 23% | 22% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 13% | 12.6% | 13.1% | 12.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.9% | 4.5% | 4.4% | 2.8% |
| EPS Diluted | 2.54 | 2.24 | 1.83 | 1.25 |
| % Growth | 13.4% | 22.4% | 46.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |